---
figid: PMC11048329__cancers-16-01533-g003
figtitle: Schematic presentation of current evidence on Cx32 association with signaling
  pathways regulating proliferative and cell death processes
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11048329
filename: cancers-16-01533-g003.jpg
figlink: /pmc/articles/PMC11048329/figure/F3
number: F3
caption: Schematic presentation of current evidence on Cx32 association with signaling
  pathways regulating proliferative and cell death processes. Cx32 inhibits the PI3K/Akt
  pathway, sensitizing HCC cells to doxorubicin, inhibits cell migration and invasion
  via p53 regulation, and enhances necroptosis via RIPK3/MLKL regulation. Regarding
  cell growth and proliferation, Cx32, despite activating ERK via the EGFR pathway,
  decreases CSCs expansion via the PI3K/Akt pathway blockage, demonstrating an anti-tumorigenic
  effect. Created with BioRender.com
papertitle: 'Understanding the Role of Connexins in Hepatocellular Carcinoma: Molecular
  and Prognostic Implications'
reftext: Stavros P. Papadakos, et al. Cancers (Basel). 2024 Apr;16(8).
year: '2024'
doi: 10.3390/cancers16081533
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: connexins | gap junctions | hepatocellular carcinoma | expression | chemosensitivity
automl_pathway: 0.8978589
figid_alias: PMC11048329__F3
figtype: Figure
redirect_from: /figures/PMC11048329__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11048329__cancers-16-01533-g003.html
  '@type': Dataset
  description: Schematic presentation of current evidence on Cx32 association with
    signaling pathways regulating proliferative and cell death processes. Cx32 inhibits
    the PI3K/Akt pathway, sensitizing HCC cells to doxorubicin, inhibits cell migration
    and invasion via p53 regulation, and enhances necroptosis via RIPK3/MLKL regulation.
    Regarding cell growth and proliferation, Cx32, despite activating ERK via the
    EGFR pathway, decreases CSCs expansion via the PI3K/Akt pathway blockage, demonstrating
    an anti-tumorigenic effect. Created with BioRender.com
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - EGFR
  - TNFRSF1A
  - TNF
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - PTK2B
  - GJB1
  - CCND1
  - SRC
  - FGR
  - FYN
  - YES1
  - KRAS
  - HRAS
  - NRAS
  - RIPK1
  - RIPK3
  - PTK2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MLKL
  - MAPK3
  - MAPK1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - KNTC1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - RPS6KB1
  - RPS6KB2
  - EPHB2
  - HDAC1
  - TP53
  - TP63
  - TP73
  - RAS
  - MEK
  - doxorubicin
---
